Ameritox invests in depression blood test with Ridge licensing deal
This article was originally published in Clinica
Executive Summary
Pain medication monitoring specialist Ameritox is branching out into depression after signing a deal that will allow it to sell Ridge Diagnostics' blood test for major depressive disorder, MDDScore, to primary care and pain physicians. Ridge claims the product is the first clinically-available blood test for depression – albeit to a very limited market for now – and CEO Lonna Williams told Clinica the company hasn't "seen anything else on the horizon".
You may also be interested in...
What are the hottest innovations from Israel?
Israel is well-known as a medtech hot-spot, with a focus on academic research and strong government support helping the country punch well above its weight when it comes to innovative devices.
EuroPCR: St Jude and Philips talk up rival intravascular imaging techs
St Jude Medical had a heavy focus on its intravascular imaging offering at this year’s EuroPCR meeting, presenting data supporting its optical coherence tomography (OCT) technology. OCT provides intravascular images to help assess culprit lesions, which can improve stent selection and deployment, according to St Jude.
EuroPCR: Medtronic's drug-coated balloon keeps rising
A big topic at this year’s EuroPCR, held in Paris on 19-22 May, was drug-coated balloons (DCBs). One of the leaders in the field, Medtronic, presented positive data from two studies of its IN.PACT Admiral balloon, which could support an expanded indication for the device.